Your browser doesn't support javascript.
loading
Benefit-Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis.
Conaghan, Philip; Cohen, Stanley; Burmester, Gerd; Mysler, Eduardo; Nash, Peter; Tanaka, Yoshiya; Rigby, William; Patel, Jayeshkumar; Shaw, Tim; Betts, Keith A; Patel, Pankaj; Liu, Jianzhong; Sun, Rochelle; Fleischmann, Roy.
Afiliação
  • Conaghan P; Leeds Institute of Rheumatic and Musculoskeletal Medicine, National Institute for Health Research, Leeds Biomedical Research Centre-University of Leeds, Leeds, UK.
  • Cohen S; Metroplex Clinical Research Center, Dallas, TX, USA.
  • Burmester G; Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Mysler E; Organización Médica de Investigación, Buenos Aires, Argentina.
  • Nash P; Griffith University, Brisbane, Queensland, Australia.
  • Tanaka Y; The First Department of Internal Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
  • Rigby W; Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
  • Patel J; AbbVie, Inc, 26525 N Riverwoods Blvd, Mettawa, North Chicago, IL, 60045, USA. jayesh.patel@abbvie.com.
  • Shaw T; AbbVie Ltd, Maidenhead, UK.
  • Betts KA; Analysis Group, Inc, Los Angeles, CA, USA.
  • Patel P; AbbVie, Inc, 26525 N Riverwoods Blvd, Mettawa, North Chicago, IL, 60045, USA.
  • Liu J; AbbVie, Inc, 26525 N Riverwoods Blvd, Mettawa, North Chicago, IL, 60045, USA.
  • Sun R; Analysis Group, Inc, Boston, MA, USA.
  • Fleischmann R; Metroplex Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Rheumatol Ther ; 9(1): 191-206, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34816388
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Rheumatol Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Rheumatol Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido